Silo Pharma, Inc. SEC filings SILO
Silo Pharma, Inc. has 378 filings in SEC EDGAR's recent list, going back to Mar 30, 2011. Its latest annual report, Form ARS, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 6, 2026 | — |
| D | Filing | Jul 14, 2026 | — |
| EFFECT | Filing | Apr 15, 2026 | — |
| EFFECT | Filing | Apr 13, 2026 | — |
| EFFECT | Filing | Nov 26, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| EFFECT | Filing | May 15, 2025 | — |
| CORRESP | Letter to the SEC | May 12, 2025 | — |
| CORRESP | Letter to the SEC | Apr 30, 2025 | — |
| CORRESP | Letter to the SEC | Apr 28, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2025 | — |
| DRS | Filing | Apr 11, 2025 | — |
| EFFECT | Filing | Apr 3, 2025 | — |
| DEFR14A | Proxy statement | Nov 15, 2024 | — |
| EFFECT | Filing | Sep 3, 2024 | — |
| CORRESP | Letter to the SEC | Aug 29, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2024 | — |
| D | Filing | Aug 2, 2024 | — |
| EFFECT | Filing | Jul 30, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2024 | — |
| D | Filing | Jun 11, 2024 | — |
| EFFECT | Filing | Jan 30, 2024 | — |
| CORRESP | Letter to the SEC | Jan 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2024 | — |
| 8-K12B | Current report | Dec 20, 2023 | Dec 19, 2023 |
| CERT | 8a cert | Sep 27, 2022 | — |
| EFFECT | Filing | Sep 26, 2022 | — |
| 8-A12B | For registration of certain classes | Sep 26, 2022 | — |
| CORRESP | Letter to the SEC | Sep 22, 2022 | — |
| CORRESP | Letter to the SEC | Sep 22, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2021 | — |
| EFFECT | Filing | Apr 12, 2021 | — |
| CORRESP | Letter to the SEC | Apr 8, 2021 | — |
| D | Filing | Feb 22, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2021 | — |
| EFFECT | Filing | Jun 4, 2020 | — |
| CORRESP | Letter to the SEC | Jun 2, 2020 | — |
| UPLOAD | Letter from the SEC | May 29, 2020 | — |
| D | Filing | May 8, 2020 | — |
| D | Filing | Dec 18, 2019 | — |
| NT 10-K | Notification of late filing | Apr 1, 2019 | Dec 31, 2018 |
| D | Filing | Dec 18, 2018 | — |
| N-54C | Filing | Sep 28, 2018 | — |
| 40-17G | Fidelity bond | Mar 2, 2018 | — |
| NT 10-Q | Notification of late filing | May 15, 2017 | Mar 31, 2017 |
| 40-17G | Bond | Mar 27, 2017 | — |
| NT 10-Q | Notification of late filing | Aug 15, 2016 | Jun 30, 2016 |
| NT 10-Q | Notification of late filing | May 17, 2016 | Mar 31, 2016 |
| NT 10-K | Notification of late filing | Mar 30, 2016 | Dec 31, 2015 |
| 40-17G | Fidelity bond | Mar 29, 2016 | — |
| CORRESP | Letter to the SEC | Nov 27, 2015 | — |
| NT 10-Q | Notification of late filing | Nov 16, 2015 | Sep 30, 2015 |
| 40-17G | Filing | Feb 2, 2015 | — |
| D | Filing | Jul 7, 2014 | — |
| 40-17G | Filing | Jan 23, 2014 | — |
| D/A | Filing | Oct 11, 2013 | — |
| N-54A | Notification of election | Oct 4, 2013 | — |
| D | Filing | Jun 7, 2013 | — |
| 8-A12G | Form 8-a | Dec 26, 2012 | — |
| D | Filing | Nov 22, 2011 | — |
| EFFECT | Filing | Jul 20, 2011 | — |
| CORRESP | Letter to the SEC | Jul 18, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2011 | — |
| CORRESP | Letter to the SEC | Jun 7, 2011 | — |
| UPLOAD | Letter from the SEC | May 27, 2011 | — |
| CORRESP | Letter to the SEC | May 11, 2011 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2011 | — |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SILO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1514183
- Former names
- Uppercut Brands, Inc. (until Aug 14, 2020); Point Capital, Inc. (until May 14, 2019); Gold Swap Inc (until Jan 7, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.